Match each clinical presentation with the most appropriate, guideline-directed primary antimicrobial therapy.
- A 24-year-old pregnant woman in her first trimester presents with an expanding erythematous targetoid rash and mild fatigue after a recent camping trip.Oral amoxicillin
- A 65-year-old man develops profuse, foul-smelling watery diarrhea and marked leukocytosis two weeks after completing treatment for community-acquired pneumonia.Oral fidaxomicin
- A 30-year-old man presents with a solitary, painless, indurated penile ulcer and bilateral inguinal lymphadenopathy; non-treponemal serology is reactive.Intramuscular penicillin G benzathine
- A 45-year-old woman with a history of injection drug use presents with high fever, a new holosystolic murmur, and blood cultures yielding methicillin-susceptible Staphylococcus aureus.Intravenous cefazolin
- A 19-year-old college student presents with sudden-onset fever, headache, nuchal rigidity, and a rapidly spreading petechial rash; cerebrospinal fluid analysis reveals Gram-negative diplococci.Intravenous ceftriaxone
Cevap
Lyme disease in pregnancy matches with oral amoxicillin; Clostridioides difficile infection matches with oral fidaxomicin; primary syphilis matches with intramuscular penicillin G benzathine; MSSA endocarditis matches with intravenous cefazolin; meningococcal meningitis matches with intravenous ceftriaxone.
Each patient presentation maps to a specific, guideline-directed antimicrobial agent. Amoxicillin is safe for Lyme disease in pregnancy. Fidaxomicin is the preferred initial treatment for C. difficile. Penicillin G benzathine is the definitive therapy for primary syphilis. Cefazolin is superior for MSSA endocarditis. Ceftriaxone provides necessary CNS penetration for meningococcal meningitis.
Adım Adım Çözüm
Anahtar Kavram
Targeted antimicrobial selection based on pathogen profile, site of infection, and host factors.